• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创新型 VTE 研究:迈向全球合作,加速静脉血栓栓塞症的临床研究。

Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism.

机构信息

The Ottawa Hospital Research Institute, 501 Smyth Rd., Ottawa, ON K1H 8L6, Canada; The Department of Medicine, The Ottawa Hospital, General Campus, 501 Smyth Rd., Ottawa, ON K1H 8L6, Canada; University of Ottawa, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada; International Network of Venous Thromboembolism Clinical Research Networks (INVENT), Canada.

The Ottawa Hospital Research Institute, 501 Smyth Rd., Ottawa, ON K1H 8L6, Canada; International Network of Venous Thromboembolism Clinical Research Networks (INVENT), Canada.

出版信息

Thromb Res. 2018 Mar;163:128-131. doi: 10.1016/j.thromres.2018.01.050. Epub 2018 Jan 31.

DOI:10.1016/j.thromres.2018.01.050
PMID:29407624
Abstract

Venous thromboembolism (VTE) represents a major global burden of disease and requires collaborative efforts to conduct large, high-quality investigator-initiated and academically sponsored studies addressing the most relevant clinical questions. Owing to increasing regulatory requirements, the highly competitive nature of peer-reviewed funding and costs associated with conducting large, multinational clinical trials, completing practice-changing research constitutes a growing challenge for clinical investigators. As clinical trialists interested in VTE, we founded INVENT (International Network of Venous Thromboembolism Clinical Research Networks) in an effort to promote and accelerate patient-oriented, investigator-initiated, international collaborative research, to identify, prioritize and answer key clinical research questions for patients with VTE. We report on our activities to formalize the INVENT network and our accomplishments in our first year.

摘要

静脉血栓栓塞症(VTE)是全球重大疾病负担之一,需要协同努力开展大型高质量的由研究者发起和学术机构赞助的研究,以解决最相关的临床问题。由于监管要求不断提高、同行评议资助的高度竞争性以及开展大型跨国临床试验相关成本的增加,完成改变实践的研究对临床研究者来说构成了越来越大的挑战。作为对 VTE 感兴趣的临床试验研究者,我们成立了 INVENT(静脉血栓栓塞症临床研究网络国际网络),努力促进和加速以患者为中心、由研究者发起的国际合作研究,以确定、优先考虑并回答 VTE 患者的关键临床研究问题。我们报告了我们为使 INVENT 网络正式化而开展的活动以及我们在第一年取得的成果。

相似文献

1
Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism.创新型 VTE 研究:迈向全球合作,加速静脉血栓栓塞症的临床研究。
Thromb Res. 2018 Mar;163:128-131. doi: 10.1016/j.thromres.2018.01.050. Epub 2018 Jan 31.
2
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).静脉血栓栓塞症、易栓症、抗栓治疗与妊娠:美国胸科医师学会循证临床实践指南(第8版)
Chest. 2008 Jun;133(6 Suppl):844S-886S. doi: 10.1378/chest.08-0761.
3
Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.非维生素K拮抗剂口服抗凝药在静脉血栓栓塞管理中的获益-风险概况
Thromb Haemost. 2015 Feb;113(2):231-46. doi: 10.1160/TH14-06-0484. Epub 2014 Oct 16.
4
The role of heparin lead-in in the real-world management of acute venous thromboembolism: The PREFER in VTE registry.肝素导入在急性静脉血栓栓塞症真实世界管理中的作用:PREFER in VTE 登记研究。
Thromb Res. 2017 Sep;157:181-188. doi: 10.1016/j.thromres.2017.07.029. Epub 2017 Jul 28.
5
Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?美国处方模式评估:癌症相关静脉血栓栓塞的治疗指南是否得到遵循?
Thromb Res. 2016 Sep;145:51-3. doi: 10.1016/j.thromres.2016.07.013. Epub 2016 Jul 26.
6
Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada.在加拿大,阿哌沙班延长治疗用于治疗和预防复发性静脉血栓栓塞的临床及经济效益。
J Med Econ. 2016 Jun;19(6):557-67. doi: 10.3111/13696998.2016.1141780. Epub 2016 Feb 3.
7
Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis.抗凝剂和阿司匹林用于静脉血栓栓塞症延长治疗的比较疗效和安全性:网状荟萃分析。
Thromb Res. 2015 May;135(5):888-96. doi: 10.1016/j.thromres.2015.02.032. Epub 2015 Mar 4.
8
Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study.基于北里-静脉血栓栓塞症(Hokusai-VTE)研究的依度沙班治疗静脉血栓栓塞症的成本效益
Hosp Pract (1995). 2015;43(5):249-57. doi: 10.1080/21548331.2015.1099412. Epub 2015 Nov 7.
9
Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism.直接口服抗凝剂用于静脉血栓栓塞症长期治疗的安全性和有效性。
Intern Emerg Med. 2016 Oct;11(7):895-900. doi: 10.1007/s11739-016-1521-8. Epub 2016 Aug 22.
10
What have we learned from real-world NOAC studies in venous thromboembolism treatment?我们从静脉血栓栓塞治疗的真实世界 NOAC 研究中学到了什么?
Thromb Res. 2018 Mar;163:83-91. doi: 10.1016/j.thromres.2018.01.034. Epub 2018 Feb 6.

引用本文的文献

1
Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemic.评估COVID-19大流行之前及期间静脉血栓栓塞症研究人员之间的研究合作网络。
Blood Vessel Thromb Hemost. 2024 Feb 24;1(1):100004. doi: 10.1016/j.bvth.2024.100004. eCollection 2024 Mar.
2
Pilot trials in thrombosis: Purpose and pitfalls.血栓形成的试点试验:目的与陷阱
Res Pract Thromb Haemost. 2018 Jun 13;2(3):572-579. doi: 10.1002/rth2.12117. eCollection 2018 Jul.